Scarica l'app Stockscreener
125.17
0.61%
0.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AXSM Giù?
Forum
Previsione
Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie
Point72 Europe London LLP Has $1.76 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Russell Investments Group Ltd. Trims Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
PDT Partners LLC Increases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc2025 Key Lessons & Reliable Breakout Forecasts - Newser
Cormorant Asset Management LP Trims Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc.July 2025 Analyst Calls & Weekly Stock Breakout Alerts - Newser
Ieq Capital LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome therapeutics director Saad sells $1.14 million in shares By Investing.com - Investing.com Australia
Axsome therapeutics director Saad sells $1.14 million in shares - Investing.com
Ranking Axsome Therapeutics Inc. among high performing stocks via toolsQuarterly Profit Review & High Accuracy Buy Signal Tips - Newser
Applying big data sentiment scoring on Axsome Therapeutics Inc.July 2025 PreEarnings & Weekly High Momentum Picks - Newser
Landscape Capital Management L.L.C. Makes New $632,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Published on: 2025-09-05 14:08:02 - Newser
Is Axsome Therapeutics Inc. a stock for growth or value investorsWeekly Profit Recap & High Conviction Buy Zone Picks - خودرو بانک
Best data tools to analyze Axsome Therapeutics Inc. stockTrade Signal Summary & Technical Pattern Alert System - Newser
Using AI based signals to follow Axsome Therapeutics Inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser
BVF Inc. IL Increases Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Why Axsome Therapeutics Inc. is moving today2025 Historical Comparison & Smart Investment Allocation Tips - Newser
Custom watchlist performance reports with Axsome Therapeutics Inc.Weekly Investment Report & Fast Entry Momentum Alerts - Newser
Multi asset correlation models including Axsome Therapeutics Inc.Earnings Trend Report & High Conviction Investment Ideas - Newser
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Axsome Therapeutics at Cantor Conference: Strategic Growth in Brain Health By Investing.com - Investing.com Canada
Driehaus Capital Management LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics Inc.’s growth already priced inCPI Data & Safe Swing Trade Setup Alerts - khodrobank.com
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years - The Globe and Mail
Will Axsome Therapeutics Inc. bounce back from current supportWeekly Gains Summary & High Return Trade Opportunity Guides - Newser
Forecasting Axsome Therapeutics Inc. price range with options dataJuly 2025 Review & Weekly High Potential Alerts - Newser
Wells Fargo Initiates Coverage on Axsome Therapeutics with Overweight Rating and $163 Price Target - AInvest
Relative strength of Axsome Therapeutics Inc. in sector analysisQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Sector ETF performance correlation with Axsome Therapeutics Inc.Volume Spike & Proven Capital Preservation Methods - Newser
Using Bollinger Bands to evaluate Axsome Therapeutics Inc.Portfolio Growth Summary & Momentum Based Trading Signals - Newser
Applying chart zones and confluence areas to Axsome Therapeutics Inc.July 2025 EndofMonth & Safe Capital Growth Tips - Newser
Is now a turning point for Axsome Therapeutics Inc.Dip Buying & Verified Swing Trading Watchlist - Newser
Axsome at Wells Fargo Conference: Growth and Strategic Expansions - Investing.com
Axsome initiated with Overweight at Wells Fargo on Alzheimer's drug potential - MSN
Wells Fargo Initiates Axsome Therapeutics with Overweight Rating, $163 Price Target - AInvest
Axsome Therapeutics Insider Sold Shares Worth $7,303,400, According to a Recent SEC Filing - 富途牛牛
Why Is Axsome (AXSM) Up 19.2% Since Last Earnings Report? - ca.finance.yahoo.com
Will Axsome Therapeutics Inc. stock recover after recent dropEarnings Trend Report & Technical Buy Zone Confirmation - Newser
What to do if you’re stuck in Axsome Therapeutics Inc.Watch List & Safe Capital Investment Plans - Newser
What’s the recovery path for long term holders of Axsome Therapeutics Inc.2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Axsome Therapeutics stock rated Overweight by Wells Fargo - Investing.com Australia
Published on: 2025-09-03 05:51:54 - Newser
Tema Etfs LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Chart based analysis of Axsome Therapeutics Inc. trendsCPI Data & Weekly Top Performers Watchlists - Newser
What’s next for Axsome Therapeutics Inc. stock price2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
What earnings revisions data tells us about Axsome Therapeutics Inc.Trade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
Published on: 2025-09-03 02:19:56 - Newser
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):